The cytosine deaminase APOBEC3B affects responses to therapy in estrogen receptor positive breast cancer cells

被引：0
|
作者：
LaPara, Kelly S.
Law, Emily
Harris, Reuben
Yee, Douglas
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-295
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页数：3
相关论文
共 50 条
  • [11] APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status
    Udquim, Krizia-Ivana
    Zettelmeyer, Clara
    Banday, A. Rouf
    Lin, Seraph Han-Yin
    Prokunina-Olsson, Ludmila
    CARCINOGENESIS, 2020, 41 (08) : 1030 - 1037
  • [12] Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B
    Shi, Ke
    Demir, Ozlem
    Carpenter, Michael A.
    Wagner, Jeff
    Kurahashi, Kayo
    Harris, Reuben S.
    Amaro, Rommie E.
    Aihara, Hideki
    SCIENTIFIC REPORTS, 2017, 7
  • [13] Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B
    Ke Shi
    Özlem Demir
    Michael A. Carpenter
    Jeff Wagner
    Kayo Kurahashi
    Reuben S. Harris
    Rommie E. Amaro
    Hideki Aihara
    Scientific Reports, 7
  • [14] Identification and functional analysis of interacting proteins for DNA cytosine deaminase APOBEC3B
    Kazuma, Yasuhiro
    Shirakawa, Kotaro
    Matsui, Hiroyuki
    Yamazaki, Hiroyuki
    Matsumoto, Tadahiko
    Ito, Shinji
    Hirabayashi, Shigeki
    Takaori, Akifumi
    CANCER SCIENCE, 2018, 109 : 578 - 578
  • [15] The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
    Serebrenik, Artur A.
    Argyris, Prokopios P.
    Jarvis, Matthew C.
    Brown, William L.
    Bazzaro, Martina
    Vogel, Rachel I.
    Erickson, Britt K.
    Lee, Sun-Hee
    Goergen, Krista M.
    Maurer, Matthew J.
    Heinzen, Ethan P.
    Oberg, Ann L.
    Huang, Yajue
    Hou, Xiaonan
    Weroha, S. John
    Kaufmann, Scott H.
    Harris, Reuben S.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3397 - 3407
  • [16] High levels of APOBEC3B, a DNA deaminase and an enzymatic source of C-to-T transitions, are a validated marker of poor outcome in estrogen receptor-positive breast cancer
    Sieuwerts, A. M.
    Burns, M.
    Look, M. P.
    Meijer-Van Gelder, M. E.
    Schlicker, A.
    Heidemann, M. R.
    Jacobs, H.
    Wessels, L.
    Willis, S.
    Leyland-Jones, B.
    Gray, K.
    Foekens, J. A.
    Harris, R. S.
    Martens, J. W.
    CANCER RESEARCH, 2013, 73
  • [17] APOBEC3B drives mutagenesis in breast cancer
    Harris, R. S.
    CANCER RESEARCH, 2013, 73
  • [18] The DNA Cytosine Deaminase APOBEC3B (A3B) is Overexpressed and Enzymatically Active in Malignant Melanomas of the Skin
    Argyris, Prokopios
    Naumann, Jordan
    Song, Kyu Young
    Koutlas, Ioannis
    Giubellino, Alessio
    Harris, Reuben S.
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 317 - 317
  • [19] The DNA Cytosine Deaminase APOBEC3B (A3B) is Overexpressed and Enzymatically Active in Malignant Melanomas of the Skin
    Argyris, Prokopios
    Naumann, Jordan
    Song, Kyu Young
    Koutlas, Ioannis
    Giubellino, Alessio
    Harris, Reuben S.
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 317 - 317
  • [20] Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
    Akre, Monica K.
    Starrett, Gabriel J.
    Quist, Jelmar S.
    Temiz, Nuri A.
    Carpenter, Michael A.
    Tutt, Andrew N. J.
    Grigoriadis, Anita
    Harris, Reuben S.
    PLOS ONE, 2016, 11 (05):
12345